|
Bowel
|
Benefits, harms and costs of potential age-extensions to the National Bowel Cancer Screening Program in Australia: Impact of inviting people aged 40-49 years and 75-84 years
|
Cancer Epidemiology, Biomarkers and Prevention
|
2018
|
|
|
Bowel
|
Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia
|
International Journal of Cancer
|
2018
|
|
|
Cervix
|
Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: example from New Zealand
|
Vaccine
|
2018
|
|
|
Cervix
|
The projected timeframe until cervical cancer elimination in Australia
|
The Lancet Public Health
|
2018
|
|
|
Cervix
|
Australia on-track to be the first country to achieve cervical cancer elimination
|
HPV World
|
2018
|
|
|
Cervix
|
HPV and Oropharyngeal Cancer among Indigenous Australians: Study Protocol
|
JMIR Resarch Protocols
|
2018
|
|
|
Cervix
|
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia
|
PLoS One
|
2018
|
|
|
Lung
|
Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia
|
Journal of Thoracic Oncology
|
2018
|
|
|
Bowel
|
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
|
The Lancet Public Health
|
2017
|
|
|
Cervix
|
Cost-effectiveness estimates: the need for complete reporting Authors' reply
|
The Lancet Public Health
|
2017
|
|
|
Cervix
|
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program
|
The Lancet Public Health
|
2017
|
|
|
Cervix
|
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
|
PLoS One
|
2017
|
|
|
Cervix
|
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country
|
International Journal of Cancer
|
2017
|
|
|
Cervix
|
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
|
International Journal of Cancer
|
2016
|
|
|
Cervix
|
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
|
The Lancet Public Health
|
2016
|
|
|
Cervix
|
Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
|
PLoS ONE
|
2016
|
|
|
Cervix
|
Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
|
BMC Health Services Research
|
2016
|
|
|
Cervix
|
Impact of+A15 HPV sample self-collection for underscreened women in the renewed National Cervical Screening Program
|
Medical Journal of Australia
|
2016
|
|
|
Cervix
|
Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis
|
The Lancet Public Health
|
2016
|
|
|
Cervix
|
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
|
Health Technology Assessment
|
2014
|
|
|
Cervix
|
Testing previous model predictions against new data on human papillomavirus vaccination program outcomes
|
BMC Research Notes
|
2014
|
|
|
Cervix
|
Incremental benefits of male HPV vaccination: Accounting for inequality in population uptake
|
PLoS One
|
2014
|
|
|
Cervix
|
Cost-effectiveness of HPV test of cure following treatment for Cervical Intraepithelial Neoplasia: Results from the NHS Sentinel Sites Study
|
BMJ
|
2012
|
|
|
Cervix
|
A revision of sexual mixing matrices in models of sexually transmitted infection
|
Statistics in Medicine
|
2012
|
|
|
Cervix
|
Expenditure and resource utilisation for cervical screening in Australia
|
BMC Health Services Research
|
2012
|
|
|
Cervix
|
The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia
|
Vaccine
|
2011
|
|
|
Cervix
|
Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study
|
BMC Cancer
|
2011
|
|
|
Cervix
|
MAVARIC a comparison of automation-assisted and manual cervical screening: a randomised controlled trial
|
Health Technology Assessment
|
2011
|
|
|
Cervix
|
Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies
|
Vaccine
|
2011
|
|
|
Cervix
|
Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
|
BMC Public Health
|
2010
|
|
|
Breast
|
A microsimulation model of the BreastScreen Australia program
|
18th World IMACS Congress and MODSIM09 International Congress on Modelling and Simulation
|
2009
|
|
|
Cervix
|
The predicted impact of vaccination on human papillomavirus infections in Australia
|
International Journal of Cancer
|
2008
|
|